• Total bilirubin 7.1 mg/dL
• Raised direct bilirubin 2.7 mg/dL
• Raised ALP 304 U/L
• Mild-moderate AST/ALT rise: 87/107 U/L

Clinical conditions to consider

1. Obstructive jaundice due to CBD stone
   • Likely clinical diagnosis if there is jaundice, dark urine, pale stools, pruritus, and right-upper-quadrant or epigastric pain.
   • The biochemical pattern supports obstruction, although the indirect bilirubin is also relatively high, which is not a purely typical obstructive pattern.
2. Acute cholangitis
   • Consider if there is fever/chills + jaundice + right-upper-quadrant pain (Charcot triad).
   • Severe cholangitis may add hypotension and altered sensorium (Reynolds pentad).
   • Check CBC with differential, CRP, blood cultures before antibiotics if possible, renal function, lactate, and ultrasound/MRCP findings.
   • This is an emergency because infected obstructed bile ducts require antibiotics and prompt biliary drainage, usually ERCP. The ASGE cholangitis guideline supports ERCP within 48 hours in cholangitis.
3. Biliary colic or persistent partial CBD obstruction
   • Episodic postprandial upper abdominal pain, nausea or vomiting, with fluctuating bilirubin and transaminases, can reflect a migrating or intermittently impacted stone.
4. Gallstone pancreatitis
   • Consider if severe persistent epigastric pain radiates to the back, with vomiting.
   • Obtain serum lipase and abdominal imaging. A transiently obstructing CBD stone can trigger pancreatitis.
5. Acute cholecystitis with choledocholithiasis
   • Possible if there is localized right-upper-quadrant tenderness, fever, positive Murphy sign, gallbladder wall thickening, pericholecystic fluid, or an impacted cystic-duct stone on ultrasound.
   • Cholecystitis alone usually does not produce this degree of jaundice, so CBD obstruction needs attention.
6. Non-stone cause contributing to hyperbilirubinemia
   • The indirect bilirubin is relatively high at 4.4 mg/dL, so consider coexisting hemolysis, Gilbert syndrome, ineffective erythropoiesis, or hepatic dysfunction if the value remains disproportionate after obstruction is relieved.
   • Check CBC, reticulocyte count, LDH, peripheral smear, haptoglobin, and repeat fractionated bilirubin.

Practical risk interpretation